Racura Oncology Surges on Trial Update
Racura Oncology (ASX: RAC) climbed 8.66 per cent on Friday to close at A$2.76, after the independent Safety Review Committee cleared the company to…
18
Skip to content
Skip to sidebar
Skip to footer
Stocks in Spotlight
View all →-
AI Stocks · Blue Chip Stocks Life360 (ASX:360): Ad Revenue Jumped 329%, So Why Did the Stock Fall? May 12, 2026 -
Tech Stocks · Growth Stocks Powerhouse Ventures (ASX:PVL) An Overlooked Deep Tech Platform Ripe for a Rerate May 6, 2026
-
AI Stocks · Semiconductor stocks Which Semiconductor Stocks Survive the Cycle, and Which Ones Get Crushed May 5, 2026
